HPLC-UV Atmospheric Pressure Ionization Mass Spectrometry Determination of the Dopamine D2 Agonist N-0923 and Its Major Metabolites After Oxidative Metabolism by Rat-, Monkey-, and Human Liver Microsomes
- 1 January 1993
- journal article
- research article
- Published by Taylor & Francis in Toxicology Mechanisms and Methods
- Vol. 3 (4) , 279-290
- https://doi.org/10.3109/15376519309068445
Abstract
An innovative custom-built atmospheric ionization source afforded an opportunity to perform on-line LC/MS analysis and to obtain identification of metabolites without need to rely on radioactive profiling. An HPLC with a UV detector coupled to a modified R 3010 triple quadrupole mass spectrometer was used in which nitrogen gas effectively prevented the clustering of ions with polar solvent molecules as well as acting as the nebulizing gas for the ionspray LC/MS interface. This approach was useful in elucidating the oxidative metabolism of the potent dopamine D2 agonist 2-(N-propyl-N-2-thienylethylamino)-5-hydroxytetralin in rat-, monkey-, and human liver microsome preparations. Microsomes from monkey showed the highest metabolic activity, with 8.3 nmol · min−1 · mg−1 protein; the human material resulted in the lowest, 1.2 nmol · min−1 · mg−1 protein. Metabolic profiling showed that the three species produced the same metabolites, but to different extents. Liver microsomes metabolized the (-) enantiomer to 2-(N-2-thienylethylamino)-5-hydroxytetralin, 2-(N-propylamino)-5-hydroxy-tetralin, and 2-(N-propyl-N-2-thienylethylamino)-5,6-dihydroxytetralin, a catechol metabolite. Due to the weak dopaminergic affinities of the N-dealkylated compounds and the high metabolic conversion of the catechol, no therapeutic effects of these compounds may be expected in vivo.Keywords
This publication has 12 references indexed in Scilit:
- Pharmacokinetics of the Dopamine D2 Agonist S(-)-2-(M-Propyl-M-2-thienylethylamino)-5-hydroxytetralin in Freely Moving RatsJournal of Pharmaceutical Sciences, 1993
- Determination of the enantiomeric purity of (−−) 2‐(N‐propyl‐n‐2‐thienylethylamino)‐5‐hydroxytetralin (n‐0923) by chiral stationary phase HPLCChirality, 1992
- The metabolic fate of the dopamine agonist 2-(N-propyl-N-2-thienylethylamino)-5-hydroxytetralin in rats after intravenous and oral administration II. Isolation and identification of metabolitesXenobiotica, 1990
- The metabolic fate of the dopamine agonist 2-(N-propyl-N-2-thienylethylamino)-5-hydroxytetralin in rats after intravenous and oral administration I. Disposition and metabolic profilingXenobiotica, 1990
- The effects of the enantiomers of the dopamine agonist N-0437 on food consumption and yawning behavior in ratsEuropean Journal of Pharmacology, 1989
- Stereoselective reversal of MPTP-induced parkinsonism in the marmoset after dermal application of N-0437European Journal of Pharmacology, 1989
- N-0437:a selective D-2 dopamine receptor agonist in in vitro and in vivo modelsEuropean Journal of Pharmacology, 1988
- Ion spray interface for combined liquid chromatography/atmospheric pressure ionization mass spectrometryAnalytical Chemistry, 1987
- The design of resolving agents. Chiral cyclic phosphoric acidsThe Journal of Organic Chemistry, 1985
- N-Alkylated 2-aminotetralins: central dopamine-receptor stimulating activityJournal of Medicinal Chemistry, 1979